home / stock / harp / harp news


HARP News and Press, Harpoon Therapeutics Inc.

Stock Information

Company Name: Harpoon Therapeutics Inc.
Stock Symbol: HARP
Market: NYSE
Website: harpoontx.com

Menu

HARP HARP Quote HARP Short HARP News HARP Articles HARP Message Board
Get HARP Alerts

News, Short Squeeze, Breakout and More Instantly...

HARP - Expected US Company Earnings on Monday, March 25th, 2024

Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...

HARP - Big Pharma patent cliffs seen fueling oncology M&A this year

2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...

HARP - Harpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Merck

2024-03-05 10:53:38 ET More on Harpoon Therapeutics Harpoon Therapeutics ticks higher after HSR waiting period for Merck deal expires Harpoon Therapeutics could see interest from other parties, Oppenheimer says Seeking Alpha’s Quant Rating on Harpoon Therapeut...

HARP - Learn to Evaluate (HARP) using the Charts

2024-02-14 02:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HARP - This 1 Bullish Move by Merck Could Drive Growth for Years to Come

2024-01-23 08:45:00 ET On Jan. 8, pharmaceutical giant Merck (NYSE: MRK) moved to acquire biotech Harpoon Therapeutics , (NASDAQ: HARP) for $680 million in cash. The point of the acquisition, which should close in the first half of this year, is to gain access to Harpoon's t...

HARP - SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AXNX, AMAM, HARP

NEW YORK, NY / ACCESSWIRE / January 20, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Axonics, Inc. (NASDAQ:AXNX)'s sa...

HARP - The 3 Best Dividend Growth Stocks to Buy in January 2024

2024-01-17 10:47:16 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Within the dividend stock portfolio, there is a case for finer diversification. First, there are blue-chip dividend stocks with stable cash flows and relatively muted dividend growth. Furth...

HARP - FDA approves Merck's Keytruda for FIGO 2014 cervical cancer

2024-01-12 18:09:53 ET More on Merck Merck & Co., Inc. (MRK) JPMorgan 42nd Annual Healthcare Conference (Slides) Merck & Co., Inc. (MRK) Presents at JPMorgan 42nd Annual Healthcare Conference (Transcript) Merck's Soaring Stock: Examining The Euphoria Amidst P...

HARP - SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates JNPR, HARP, AMAM

NEW YORK, NY / ACCESSWIRE / January 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Juniper Networks, Inc. (NYSE:JNPR)...

HARP - SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, CPE

NEW YORK, NY / ACCESSWIRE / January 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Harpoon Therapeutics, Inc. (NASDAQ...

Next 10